BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18566024)

  • 1. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.
    Hebb AL; Moore CS; Bhan V; Campbell T; Fisk JD; Robertson HA; Thorne M; Lacasse E; Holcik M; Gillard J; Crocker SJ; Robertson GS
    Mult Scler; 2008 Jun; 14(5):577-94. PubMed ID: 18566024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
    Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
    J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
    J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
    Moore CS; Hebb AL; Robertson GS
    J Neuroimmunol; 2008 Jan; 193(1-2):94-105. PubMed ID: 18055022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer.
    Hofmann HS; Simm A; Hammer A; Silber RE; Bartling B
    J Cancer Res Clin Oncol; 2002 Oct; 128(10):554-60. PubMed ID: 12384799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis.
    Mokuda S; Miyazaki T; Ubara Y; Kanno M; Sugiyama E; Takasugi K; Masumoto J
    Arthritis Res Ther; 2015 Sep; 17():275. PubMed ID: 26419626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.
    Sharief MK; Noori MA; Douglas MR; Semra YK
    Eur J Neurol; 2002 Sep; 9(5):503-10. PubMed ID: 12220382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting apoptosis to treat multiple sclerosis.
    Hebb AL; Moore CS; Bhan V; Robertson GS
    Curr Drug Discov Technol; 2008 Mar; 5(1):75-7. PubMed ID: 18537570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas.
    Ka H; Hunt JS
    Am J Pathol; 2003 Aug; 163(2):413-22. PubMed ID: 12875963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of IAP family proteins in esophageal cancer.
    Nemoto T; Kitagawa M; Hasegawa M; Ikeda S; Akashi T; Takizawa T; Hirokawa K; Koike M
    Exp Mol Pathol; 2004 Jun; 76(3):253-9. PubMed ID: 15126108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins.
    Gagarina V; Carlberg AL; Pereira-Mouries L; Hall DJ
    J Biol Chem; 2008 Jan; 283(1):648-659. PubMed ID: 17993464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells.
    Peng XH; Karna P; O'Regan RM; Liu X; Naithani R; Moriarty RM; Wood WC; Lee HY; Yang L
    Mol Pharmacol; 2007 Jan; 71(1):101-11. PubMed ID: 17035597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.
    Nomura T; Yamasaki M; Nomura Y; Mimata H
    Oncol Rep; 2005 Oct; 14(4):993-7. PubMed ID: 16142363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy.
    Sharief MK; Noori MA; Zoukos Y
    J Neuroimmunol; 2002 Aug; 129(1-2):224-31. PubMed ID: 12161039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brains.
    Christie LA; Su JH; Tu CH; Dick MC; Zhou J; Cotman CW
    Neurobiol Dis; 2007 Apr; 26(1):165-73. PubMed ID: 17292615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
    Mizutani K; Matsumoto K; Hasegawa N; Deguchi T; Nozawa Y
    Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma.
    Wagenknecht B; Glaser T; Naumann U; Kügler S; Isenmann S; Bähr M; Korneluk R; Liston P; Weller M
    Cell Death Differ; 1999 Apr; 6(4):370-6. PubMed ID: 10381630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
    Sharief MK; Semra YK
    J Neuroimmunol; 2001 Oct; 119(2):350-7. PubMed ID: 11585639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
    Seidi OA; Sharief MK
    J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.